Announced details
Research and development of veterinary drugs, veterinary medicine, and future development of human pharmaceuticals
Joint research on the research and development of a new veterinary drug.
Hokkaido University's Institute for Vaccine Research and Development and Graduate School of Veterinary Medicine. IVReD is an abbreviation for Institute for Vaccine Research and Development. Other details, including location, representative, capital, and year established, are not disclosed.
In this announcement the company addresses none of Contract Value / Offering price / Impact on Business Performance.
| Item | Details |
|---|---|
| Names of Products / Services Covered | New veterinary drug |
| Counterparty | Hokkaido University Institute for Vaccine Research and Development (IVReD), Hokkaido University Graduate School of Veterinary Medicine |
| Counterparty overview | Hokkaido University's Institute for Vaccine Research and Development and Graduate School of Veterinary Medicine. IVReD is an abbreviation for Institute for Vaccine Research and Development. Other details, including location, representative, capital, and year established, are not disclosed. |
| Relationship with the Company | Joint research on the research and development of a new veterinary drug. |
| Launch date | 13 March 2026 (joint research commenced, actual) |
| Applicable area | Research and development of veterinary drugs, veterinary medicine, and future development of human pharmaceuticals |
Items this document does not state (12)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The objective is to develop a new veterinary drug, establish a commercial manufacturing method, and pave the way for the development of human pharmaceuticals based on the concept of Zoobiquity.